Aryavan Enterprise Ltd
Incorporated in 1993, Ecofinity Atomix Ltd
is engaged in the business of trading goods.[1]
- Market Cap ₹ 34.8 Cr.
- Current Price ₹ 50.0
- High / Low ₹ 63.7 / 34.5
- Stock P/E 10.3
- Book Value ₹ 45.7
- Dividend Yield 1.00 %
- ROCE 14.9 %
- ROE 10.9 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.11 times its book value
- Company's working capital requirements have reduced from 119 days to 76.7 days
Cons
- Promoter holding is low: 37.8%
- Promoter holding has decreased over last 3 years: -26.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Iron & Steel Products
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 33.35 | 4.66 | 6.53 | 35.97 | 55.06 | |
| 33.49 | 4.98 | 6.47 | 34.20 | 51.16 | |
| Operating Profit | -0.14 | -0.32 | 0.06 | 1.77 | 3.90 |
| OPM % | -0.42% | -6.87% | 0.92% | 4.92% | 7.08% |
| 0.49 | 0.40 | 0.22 | 0.35 | 1.16 | |
| Interest | 0.08 | 0.00 | 0.00 | 0.04 | 0.18 |
| Depreciation | 0.04 | 0.01 | 0.00 | 0.08 | 0.17 |
| Profit before tax | 0.23 | 0.07 | 0.28 | 2.00 | 4.71 |
| Tax % | 43.48% | 28.57% | 3.57% | 23.50% | 26.11% |
| 0.13 | 0.06 | 0.27 | 1.53 | 3.47 | |
| EPS in Rs | 0.34 | 0.16 | 0.70 | 2.20 | 4.84 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 10.33% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 53% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 120% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 24% |
| 3 Years: | 24% |
| 1 Year: | 15% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 3.85 | 3.85 | 6.96 | 6.96 | |
| Reserves | -0.74 | -0.68 | 23.02 | 24.83 | |
| 2.05 | 5.17 | 0.24 | 3.30 | ||
| 18.37 | 4.87 | 2.45 | 11.57 | ||
| Total Liabilities | 23.53 | 13.21 | 32.67 | 46.66 | |
| 0.04 | 0.57 | 12.97 | 11.60 | ||
| CWIP | 0.00 | 0.00 | 0.00 | 7.31 | |
| Investments | 0.00 | 0.58 | 0.07 | 0.07 | |
| 23.49 | 12.06 | 19.63 | 27.68 | ||
| Total Assets | 23.53 | 13.21 | 32.67 | 46.66 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 0.00 | -4.83 | -7.25 | 4.42 | ||
| 0.00 | 0.68 | -6.16 | -6.22 | ||
| 0.00 | 3.11 | 13.46 | 2.16 | ||
| Net Cash Flow | 0.00 | -1.03 | 0.05 | 0.36 | |
| Free Cash Flow | 0.00 | -5.37 | -7.25 | -2.91 | |
| CFO/OP | 0% | 1,497% | -392% | 174% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 151.47 | 516.17 | 93.36 | 112.36 | |
| Inventory Days | 0.00 | 44.89 | 25.09 | ||
| Days Payable | 18.60 | 80.02 | |||
| Cash Conversion Cycle | 151.47 | 516.17 | 119.64 | 57.43 | |
| Working Capital Days | 0.11 | 386.15 | 161.65 | 76.70 | |
| ROCE % | 1.04% | 14.86% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Aug 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number ・Standalone data |
|
||||||||||
| Approved Solar Plant Capacity KW |
|||||||||||
| Projected Annual Solar Power Generation Lakhs KWH |
|||||||||||
| Subsidiary Ownership Stake (Padmavati Chemicals) Percentage (%) |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
RESULTS - Financial Results For Quarter And Year Ended 31/0/2026.
30 May - Board approved FY26 audited standalone and consolidated results on 30 May 2026; standalone profit ₹337.44 lakh.
-
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of SEBI ('LODR') Regulations, 2015 As Amended ('SEBI Listing Regulations').
30 May - Board approved audited standalone and consolidated results for FY26; auditors issued unmodified report.
-
Board Meeting Intimation for Consideration & Approval Of Audited Financial Results For The Quarter And Year Ended On 31St March, 2026
21 May - Board meets 30 May 2026 to approve audited standalone and consolidated FY26 results.
- Closure of Trading Window 30 Mar
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING - ISSUE OF EQUITY WARRANTS
20 Feb - Proposal (20 Feb 2026) to issue 23,90,000 warrants (₹2.39 crore) preferentially; EGM for approval.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
Business Overview:[1]
EAL (Formerly known as Aryavan Enterprise
Limited) is Trader - Wholesaler /Distributor with a 60% Stake in Bulk Drug Intermediate Partnership Firm.